Meeting
2015 Gastrointestinal Cancers Symposium
Full report of the TROG 03.01, NCIC CTG ES2 multinational phase III study in advanced esophageal cancer comparing palliation of dysphagia and quality of life in patients treated with radiotherapy or chemoradiotherapy.
Authors
Michael Gordon Penniment
Royal Adelaide Hospital, Adelaide, Australia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
ACTRN12606000526572
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 6)
DOI
10.1200/jco.2015.33.3_suppl.6
Abstract #
6
Poster Bd #
A6
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
A randomized phase III study in advanced esophageal cancer (OC) to compare the quality of life (QoL) and palliation of dysphagia in patients treated with radiotherapy (RT) or chemoradiotherapy (CRT) TROG 03.01 NCIC CTG ES.2.
First Author: Michael Gordon Penniment
Poster
2022 ASCO Annual Meeting
NANORAY-312: A phase III pivotal study of NBTXR3 activated by investigator’s choice of radiotherapy alone or radiotherapy in combination with cetuximab for platinum-based chemotherapy-ineligible elderly patients with locally advanced head and neck squamous cell carcinoma.
First Author: Christophe Le Tourneau
Poster
2021 ASCO Annual Meeting
A randomized phase II trial of diffusion-weighted MR imaging-guided radiotherapy plus chemotherapy versus standard chemoradiotherapy in locoregional advanced nasopharyngeal carcinoma.
First Author: Feng Liu